Rigrodsky & Long, P.A. Announces Investigations Of OPNET Technologies, Inc., Schiff Nutrition International, Inc. and MOD-PAC Corp. Buyouts

WILMINGTON, Del., Nov. 6, 2012 /PRNewswire/ --

OPNET Technologies, Inc.

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of OPNET Technologies, Inc. ("OPNET" or the "Company") (NASDAQ GS: OPNT) regarding possible breaches of fiduciary duties and other violations of law related to the Company's entry into an agreement to be acquired by Riverbed Technology, Inc. ("Riverbed") (NASDAQ GS: RVBD) in a transaction valued at approximately $1 billion.  Under the terms of the proposal, public shareholders of OPNET will receive $36.55 in cash and 0.2774 shares of Riverbed common stock for each share of OPNET they own.  Based on Riverbed's closing stock price of $22.62 on October 26, 2012, OPNET shareholders would have received consideration valued at approximately $42.82 per share.    

The investigation concerns whether OPNET's board of directors failed to adequately shop the Company and obtain the best possible value for OPNET's shareholders before entering into an agreement with Riverbed.  According to Yahoo! Finance, at least one analyst has set a price target for OPNET stock at $43.00 per share.                    

If you own the common stock of OPNET and purchased your shares before October 29, 2012, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Peter Allocco at Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, New York 11530 toll free at (888) 969-4242, by e-mail to info@rigrodskylong.com, or at: http://www.rigrodskylong.com/investigations/opnet-technologies-inc-opnt.          

Schiff Nutrition International, Inc.

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Schiff Nutrition International, Inc. ("Schiff" or the "Company") (NYSE: SHF) regarding possible breaches of fiduciary duties and other violations of law related to the Company's entry into an agreement to be acquired by Bayer HealthCare LLC ("Bayer") in a transaction valued at approximately $1.2 billion.  Under the terms of the proposal, public shareholders of Schiff will receive $34.00 per share in cash for each share of Schiff they own. 

The investigation concerns whether Schiff's board of directors failed to adequately shop the Company and obtain the best possible value for Schiff's shareholders before entering into an agreement with Bayer.                    

If you own the common stock of Schiff and purchased your shares before October 30, 2012, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Peter Allocco at Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, New York 11530 toll free at (888) 969-4242, by e-mail to info@rigrodskylong.com, or at: http://www.rigrodskylong.com/investigations/schiff-nutrition-international-inc-shf.         

MOD-PAC Corp.

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of MOD-PAC Corp. ("MOD-PAC" or the "Company") (NASDAQ GM: MPAC) regarding possible breaches of fiduciary duties and other violations of law related to the Company's receipt of a proposal to be acquired by a group consisting of the Company's President and Chief Executive Officer, Daniel G. Keane, and its Chairman of the Board, Kevin T. Keane.  Under the terms of the proposal, public shareholders of MOD-PAC will receive $7.20 per share in cash for each share of MOD-PAC they own.   

The investigation concerns the Company's board of directors' process for consideration of the proposed transaction, whether MOD-PAC is acting in its shareholders' best interests and whether the proposed consideration to be paid to MOD-PAC's shareholders would be fair and adequate. 

If you own the common stock of MOD-PAC and purchased your shares before October 29, 2012, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Peter Allocco at Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, New York 11530 toll free at (888) 969-4242, by e-mail to info@rigrodskylong.com, or at: http://www.rigrodskylong.com/investigations/mod-pac-corp-mpac.         

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.

CONTACT:                                                                                             

Rigrodsky & Long, P.A.
Peter Allocco
(888) 969-4242
(516) 683-3516
Fax: (302) 654-9430
info@rigrodskylong.com
http://www.rigrodskylong.com

SOURCE Rigrodsky & Long, P.A.

Copyright 2012 PR Newswire

Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more Opiant Pharmaceuticals Charts.
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more Opiant Pharmaceuticals Charts.